Structure-Guided Development of Topoisomerase IIB Isoform-Selective Inhibitors for Prevention of Anthracycline Cardiotoxicity (Abstract ID: 270109)
Anh Cong(Mayo Clinic), Matthew J. Schellenberg(Mayo Clinic), Caroline A. Austin(Newcastle University), Tomáš Šimůnek(Charles University), Jaroslav Roh(Charles University), Martin Štěrba(Charles University)
Cited by 0
Related Papers
Human topoisomerases and their roles in genome stability and organization
|Nature Reviews Molecular Cell Biology|2022|446
Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
|European Journal of Heart Failure|2020|344
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
|The EMBO Journal|2013|309